Results 51 to 60 of about 169,272 (157)

Fungal Fantasies: Series of Pulmonary Mycotic Manifestations [PDF]

open access: yesIndian Journal of Respiratory Care
Fungal involvement in the lungs, known as pulmonary mycosis, can range from mild allergic disease to life-threatening invasive fungal conditions, particularly among immunocompromised individuals and those with underlying lung diseases.
R Anand, S Raghul Raj, S Arun Pandiyan
doaj   +1 more source

TWO CASES OF ALLERGIC BRONCHOPULMONARY MYCOSIS

open access: yesNihon Shoni Arerugi Gakkaishi. The Japanese Journal of Pediatric Allergy and Clinical Immunology, 1998
We present two cases of allergic bronchopulmonary aspergillosis or allergic bronchopulmonary penicilliosis. The first cas was a 15 year-old male with bronchial asthma. Chest roentgenogram showed an infiltration shadow in the bilateral upper lung fields, predominantly in the right upper lobe.
Fujii, Katunori   +2 more
openaire   +2 more sources

A Case of Chronic Cough in a Winemaker

open access: yesRespiratory Medicine Case Reports, 2017
Background: Fungi have been known to cause a variety of respiratory conditions, ranging from mold- associated asthma to allergic bronchopulmonary mycosis and invasive disease.
Ernesto Viteri, MD   +3 more
doaj   +1 more source

[Allergic bronchopulmonary mycosis caused by Schizophyllum commune].

open access: yesNihon Kyobu Shikkan Gakkai zasshi, 1996
In December 1989, a 72-year-old woman was hospitalized with atelectasis in the left lower lobe. The atelectasis resolved after bronchoscopic removal of impacted mucous plugs. Histopathological examination showed pulmonary mycosis. Microscopy suggested that a species of Aspergillus was responsible, but no definite diagnosis was made.
Tomita, Kazuhiro   +9 more
openaire   +2 more sources

Allergic Bronchopulmonary Aspergillosis/Mycosis: An Underdiagnosed Disease

open access: yes, 2023
Allergic bronchopulmonary aspergillosis (ABPA) is an immune-allergic disease of the lung due to a hypersensitivity reaction to antigens of Aspergillus fumigatus after colonization into the airways. Predominantly, it affects patients with bronchial asthma and those having cystic fibrosis (CF).
Solange Oliveira Rodrigues Valle   +2 more
openaire   +1 more source

From Plants to Animals: Cross‐Kingdom Infection by Fungal Phytopathogens

open access: yesMycoses, Volume 69, Issue 10, October 2026.
ABSTRACT Plant pathogenic fungi exhibit significant ecological diversity that is under pressure from climate change, yet their relevance to both human and ecosystem health remains underexplored within the One Health framework. Several phytopathogenic lineages have demonstrated the ability to infect vertebrate hosts.
Aditya K. Gupta   +3 more
wiley   +1 more source

components in the diagnosis of allergic bronchopulmonary aspergillosis

open access: yes, 2021
International audienceWe read with interest the contribution by Lukaszewicz et al providing an overview of the diagnostic criteria for allergic broncho-pulmonary aspergillosis (ABPA) and mycosis (ABPM) and elaborating on the need for expanding the use of
Annesi-Maesano, Isabella   +17 more
core   +1 more source

Allergic bronchopulmonary aspergillosis presenting as nephrotic syndrome due to secondary amyloidosis: Case report and systematic review of the literature

open access: yesLung India, 2018
Allergic bronchopulmonary aspergillosis (ABPA) is a complex inflammatory lung disorder complicating bronchial asthma and cystic fibrosis. Although the condition responds to treatment with glucocorticoids and antifungal drugs, lack of timely recognition ...
Valliappan Muthu   +4 more
doaj   +1 more source

Bronchoscopy and Pathology Findings in an Unusual Case of Allergic Bronchopulmonary Mycosis

open access: yesInfectious Diseases & Immunity, 2021
. The diagnosis of allergic bronchopulmonary mycosis (ABPM) is usually made on clinical, serologic, and roentgenographic findings. However, the indicators in such diagnostic criteria still lack specificity, which results in a high rate of misdiagnosis. A
Yongqun Li   +4 more
doaj   +1 more source

Remission in Global Airway Diseases: EUFOREA Consensus Paper

open access: yesAllergy, Volume 81, Issue 9, Page 3146-3156, September 2026.
ABSTRACT The therapeutic goal in chronic airway diseases is shifting from symptom control to disease remission. Disease‐modifying therapies, including biologics and allergen immunotherapy, have made remission achievable in patients with severe asthma, chronic rhinosinusitis with nasal polyps (CRSwNP), or allergic rhinitis (AR).
J. Christian Virchow   +22 more
wiley   +1 more source

Home - About - Disclaimer - Privacy